ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

EVAX Evaxion Biotech AS

3.8894
-0.0606 (-1.53%)
最終更新日: 22:43:13
15分遅延
名称 銘柄コード 市場 種別
Evaxion Biotech AS EVAX NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-0.0606 -1.53% 3.8894 22:43:13
始値 安値 高値 終値 前日終値
3.99 3.79 3.99 3.95
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1721:00GLOBEEvaxion Announces Phase 2 Clinical Trial Update: First..
2024/4/0220:00GLOBEEvaxion and Undisclosed Collaborator Announce Encouraging..
2024/3/2720:30GLOBEEvaxion Announces Business Update and Full Year 2023..
2024/3/1920:30GLOBEEvaxion Hosts R&D Day and Unveils the Broad Potential of Its..
2024/2/2921:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2921:30GLOBEEvaxion to Host R&D Day on March 19, 2024, Highlighting its..
2024/2/2021:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2021:30GLOBEEvaxion Announces Successful Completion of the Initial..
2024/2/0806:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0722:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0722:30GLOBEEvaxion Regains Compliance with Nasdaq Minimum Bid Price..
2024/2/0622:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0622:30GLOBEEvaxion Announces Closing of $15 Million Public Offering
2024/2/0523:09EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/2/0521:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0214:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0123:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0123:20GLOBEEvaxion Biotech Announces Pricing of $15 Million Public..
2024/2/0107:10EDGAR2Form F-1/A - Registration statement for certain foreign..
2024/1/3123:26EDGAR2Form F-1/A - Registration statement for certain foreign..
2024/1/3105:16EDGAR2Form F-1/A - Registration statement for certain foreign..
2024/1/2706:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2504:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2422:30GLOBEEvaxion to Develop Tailored Novel Cancer Vaccines Based upon..
2024/1/2306:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2306:30GLOBEEvaxion Announces Completion of ADS Ratio Change
2024/1/1307:17EDGAR2Form F-1 - Registration statement for certain foreign..
2024/1/1223:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1022:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0822:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0822:30GLOBEEvaxion Announces Plan to Implement ADS Ratio Change
2023/12/2206:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2206:30GLOBEEvaxion Biotech Announces Closing of Private Placement
2023/12/2006:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2006:15GLOBEEvaxion Announces Business Update and Third Quarter 2023..
2023/12/1923:25GLOBEEvaxion Biotech Announces Private Placement Financing
2023/12/1922:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0906:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2822:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2822:27GLOBEEvaxion to Unveil Potentially Groundbreaking AI-Immunology™..
2023/11/1723:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1522:00GLOBEEvaxion Presents Proof-of-Principle for Its Unique AI Model..
2023/11/0700:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0700:12GLOBEEvaxion Shares Latest EVX-01 Phase 2 Clinical Data in..
2023/11/0100:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0100:14GLOBEEvaxion Announces Encouraging Initial Phase 2 Clinical Data..
2023/10/2621:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2621:30GLOBENew and Exciting Clinical Data on Evaxion’s..
2023/10/1405:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock